Medical Services Expenditures by Disease: Neoplasms Price Index, MEPS Account Basis

NPSMSMPIMEPS • Economic Data from Federal Reserve Economic Data (FRED)

Latest Value

135.63

Year-over-Year Change

68.69%

Date Range

1/1/2000 - 1/1/2021

Summary

The Medical Services Expenditures by Disease: Neoplasms Price Index, MEPS Account Basis tracks price changes for medical services related to the treatment of neoplasms, or cancerous growths, based on the Medical Expenditure Panel Survey (MEPS) data.

Analysis & Context

This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.

Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.

About This Dataset

This price index measures inflation in the cost of medical services for the treatment of neoplasms, which includes various types of cancer. It is an important indicator for policymakers and healthcare analysts to monitor trends in the affordability of cancer care.

Methodology

The data is collected through the MEPS household survey, which tracks medical expenditures across a nationally representative sample.

Historical Context

The index is used to assess the impact of healthcare policies and market dynamics on the cost of cancer treatment.

Key Facts

  • The index has a base year of 2001.
  • Neoplasms account for a significant share of total U.S. healthcare expenditures.
  • Rising medical costs can impact patient access to cancer treatment.

FAQs

Q: What does this economic trend measure?

A: This index measures changes in the prices of medical services specifically related to the treatment of neoplasms, or cancerous growths.

Q: Why is this trend relevant for users or analysts?

A: The cost of cancer treatment is a critical concern for patients, policymakers, and healthcare providers, making this index an important indicator of medical price inflation in this area.

Q: How is this data collected or calculated?

A: The data is collected through the Medical Expenditure Panel Survey (MEPS), a nationally representative household survey.

Q: How is this trend used in economic policy?

A: This index is used by economists and policymakers to assess the impact of healthcare policies and market dynamics on the affordability of cancer treatment.

Q: Are there update delays or limitations?

A: The MEPS data used to calculate this index may have a delay of several months before being published.

Related Trends

Citation

U.S. Federal Reserve, Medical Services Expenditures by Disease: Neoplasms Price Index, MEPS Account Basis (NPSMSMPIMEPS), retrieved from FRED.